Medical News

RSS

Daval International receives award for its anti-inflammatory agent AIMSPRO

Following the provision of clinical and scientific data to the US Food and Drug Administration (FDA), privately owned UK company Daval International Limited (http://www.davalinternational.com) has been informed that its innovative anti-inflammatory agent AIMSPRO(R) has been awarded an Orphan-Drug designation for the treatment of Amyotrophic Lateral Sclerosis (ALS).

9 Nov 2009

Family Research Council releases statement concerning the passage of pro-life amendment

Today, the House of Representatives passed the Stupak, Pitts, Kaptur, Dahlkemper, Smith, Ellsworth and Lipinski amendment to the "Affordable Health Care for America Act" (H.R. 3962). The amendment maintains the current policy of preventing federal funding for abortion and for benefits packages that include abortion.

9 Nov 2009

Dr. Charmaine Yoest: Passage of pro-life amendment, a victory for the pro-life Americans

Americans United for Life Action President and CEO Dr. Charmaine Yoest said, "The passage of this amendment is a victory for the pro-life Americans across this country who have flooded Congress this week with the message that abortion does not belong in health care. The bipartisan effort that led to its passage, under the leadership of Congressmen Bart Stupak and Joe Pitts, is a step toward a future where both political parties defend Life."

9 Nov 2009

Researchers develop tools to visualize how different cell populations of cells communicate

Using imaging mass spectrometry, researchers at the University of California, San Diego have developed tools that will enable scientists to visualize how different cell populations of cells communicate. Their study shows how bacteria talk to one another - an understanding that may lead to new therapeutic discoveries for diseases ranging from cancer to diabetes and allergies.

9 Nov 2009

With the House landmark vote behind them, GOP and Democratic leaders turn sights to the Senate

After yesterday, when the House of Representatives cleared its version of sweeping health overhaul legislation, the Sunday talk shows were full of GOP and Democratic leaders talking about the impact of that vote as well as what might happen in the Senate.

9 Nov 2009

Postmenopausal hormone therapy reduces the rate of atypical ductal hyperplasia

The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer.

9 Nov 2009

HAE patients have prodromal symptoms that signal an oncoming HAE attack, reports survey

Most patients with hereditary angioedema (HAE) have prodromal symptoms that signal an oncoming HAE attack giving the patients sufficient time to initiate treatment and decrease the morbidity associated with that attack, according to survey findings presented today at the 2009 American College of Allergy, Asthma & Immunology (ACAAI) Annual Meeting.

9 Nov 2009

HUYA Bioscience International and School of Medicine and Pharmacy enter into partnership agreement

HUYA Bioscience International, a leader in globalizing China's biopharmaceutical innovation, today announced a strategic partnership with the School of Medicine and Pharmacy, Ocean University of China.

9 Nov 2009

Sonova Holding enters into a share purchase agreement with shareholders of Advanced Bionics

Sonova Holding AG, the world's leading provider of hearing systems, announced today that it has entered into a share purchase agreement with the shareholders of Advanced Bionics Corporation, Los Angeles, USA.

9 Nov 2009

Democrats' late-night abortion agreement opens door to vote on health bill

News outlets covered the late-night deal on abortion language in the House health care overhaul bill.

9 Nov 2009

Health Canada accepts for review the EpiCept’s New Drug Submission for Ceplene

EpiCept Corporation today announced that Health Canada has accepted for review the Company’s New Drug Submission (NDS) for Ceplene® (histamine dihydrochloride) for the remission maintenance of acute myeloid leukemia (AML) patients in first complete remission.

9 Nov 2009

Symposium on non invasive diagnosis and management of hepatic fibrosis sponsored by Echosens

Echosens, the French high-technology company specializing in non-invasive diagnostics in hepatology is the official sponsor of the Symposium held by Pr Sarin in the Famous Institute of liver and Biliary Sciences of New Delhi today. This symposium will focus on the non invasive diagnosis and management of hepatic fibrosis, with speakers from all around the world.

9 Nov 2009

Research projects in the areas of mathematics and biochemistry score top marks

Research projects in the areas of mathematics and biochemistry scored top marks this evening, as Tim Kunisky of Livingston, NJ and the team of Benjamin Song and Quan (Jack) Chen of Audubon, PA received the highest honors at the Region Five Finals of the 2009 Siemens Competition in Math, Science & Technology, the nation's premier high school science competition.

9 Nov 2009

Specialization in one sport increases the risk of injury, find researchers

Gifted young athletes are under increasing pressure to play only one sport year round.

9 Nov 2009

Evaluation of DX-88 to resolve symptoms of acute HAE attacks to be presented

An analysis demonstrating the ability of DX-88 (ecallantide) to resolve symptoms of acute hereditary angioedema (HAE) attacks in all anatomic locations and to sustain effect will be presented in an oral presentation this week at the American College of Allergy, Asthma and Immunology (ACAAI) 2009 Annual Meeting in Miami Beach.

9 Nov 2009

A divided House approves sweeping health reform legislation, 220-215

After months of intense debate and negotiations, the House of Representatives approved the most ambitious effort ever to change the country's health care system, with 219 Democrats and one Republican voting for the bill and 39 Democrats voting against the bill. Democrats in the chamber cheered the final tally.

9 Nov 2009

Patients with highest breast density have greater risk of cancer recurrence, find researchers

A new study finds that women treated for breast cancer are at higher risk of cancer recurrence if they have dense breasts. Published in the December 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study's results indicate that breast cancer patients with dense breasts may benefit from additional therapies following surgery, such as radiation.

9 Nov 2009

TNS files Provisional Use Patent application on the ability of a natural organic mushroom formula

Total Nutraceutical Solutions, Inc. (TNS), announced that it has filed a Provisional Use Patent application on the ability of a proprietary natural organic mushroom formula to control oxidative stress.

9 Nov 2009

PhRMA releases statement regarding the House health care reform bill

We are disappointed, but not surprised by today's vote -- an uneasiness echoed by millions of hardworking Americans as well as nearly half of the members of the U.S. House of Representatives who voted against the bill.

9 Nov 2009

C1-INH concentrate, an effective therapy to treat acute swelling attacks for HAE

Patients reported C1-esterase inhibitor (C1-INH) concentrate is an effective therapy in treating acute swelling attacks at any body location for HAE, a rare and serious genetic disorder, according to data presented today at the 2009 American College of Allergy, Asthma & Immunology (ACAAI) Annual Meeting.

9 Nov 2009

Medical News

Daval International receives award for its anti-inflammatory agent AIMSPRO

Family Research Council releases statement concerning the passage of pro-life amendment

Dr. Charmaine Yoest: Passage of pro-life amendment, a victory for the pro-life Americans

Researchers develop tools to visualize how different cell populations of cells communicate

With the House landmark vote behind them, GOP and Democratic leaders turn sights to the Senate

Postmenopausal hormone therapy reduces the rate of atypical ductal hyperplasia

HAE patients have prodromal symptoms that signal an oncoming HAE attack, reports survey

HUYA Bioscience International and School of Medicine and Pharmacy enter into partnership agreement

Sonova Holding enters into a share purchase agreement with shareholders of Advanced Bionics

Democrats' late-night abortion agreement opens door to vote on health bill

Health Canada accepts for review the EpiCept’s New Drug Submission for Ceplene

Symposium on non invasive diagnosis and management of hepatic fibrosis sponsored by Echosens

Research projects in the areas of mathematics and biochemistry score top marks

Specialization in one sport increases the risk of injury, find researchers

Evaluation of DX-88 to resolve symptoms of acute HAE attacks to be presented

A divided House approves sweeping health reform legislation, 220-215

Patients with highest breast density have greater risk of cancer recurrence, find researchers

TNS files Provisional Use Patent application on the ability of a natural organic mushroom formula

PhRMA releases statement regarding the House health care reform bill

C1-INH concentrate, an effective therapy to treat acute swelling attacks for HAE

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News